Clinical Research Directory
Browse clinical research sites, groups, and studies.
Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
Sponsor: Mayo Clinic
Summary
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
101
Start Date
2026-06-01
Completion Date
2026-06
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
Oral Tranexamic Acid
Subjects will receive a 1.95 g dose of oral TXA at the following timepoints: (1) following ambulation, (2) postoperative day 1, (3) postoperative day 2, and (4) postoperative day 3
Locations (1)
Mayo Clinic in Arizona
Scottsdale, Arizona, United States